These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 12161155)
1. 1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT(7) receptor ligands. Isaac MB; Xin T; O'Brien A; St-Martin D; Naismith A; MacLean N; Wilson J; Demchyshyn L; Tehim A; Slassi A Bioorg Med Chem Lett; 2002 Sep; 12(17):2451-4. PubMed ID: 12161155 [TBL] [Abstract][Full Text] [Related]
2. 6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists. Isaac M; Slassi A; Xin T; MacLean N; Wilson J; McCallum K; Wang H; Demchyshyn L Bioorg Med Chem Lett; 2000 Aug; 10(15):1719-21. PubMed ID: 10937732 [TBL] [Abstract][Full Text] [Related]
3. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists. Cole DC; Ellingboe JW; Lennox WJ; Mazandarani H; Smith DL; Stock JR; Zhang G; Zhou P; Schechter LE Bioorg Med Chem Lett; 2005 Jan; 15(2):379-83. PubMed ID: 15603958 [TBL] [Abstract][Full Text] [Related]
14. Influence of the terminal amide fragment geometry in some 3-arylideneindolin-2(1H)-ones on their 5-HT1A/5-HT2A receptor activity. Mokrosz MJ; Charakchieva-Minol S; Kozioł A; Kłodzińska A; Chojnacka-Wójcik E Bioorg Med Chem Lett; 2001 May; 11(9):1229-31. PubMed ID: 11354383 [TBL] [Abstract][Full Text] [Related]
15. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists. Crawforth J; Goodacre S; Maxey R; Bourrain S; Patel S; Marwood R; O'Connor D; Herbert R; Hutson P; Rowley M Bioorg Med Chem Lett; 2000 Dec; 10(24):2701-3. PubMed ID: 11133072 [TBL] [Abstract][Full Text] [Related]
16. N-[(1-butyl-4-piperidinyl)methyl]-3,4dihydro-2H-[1,3]oxazino[3,2- a]indole10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity. Gaster LM; Joiner GF; King FD; Wyman PA; Sutton JM; Bingham S; Ellis ES; Sanger GJ; Wardle KA J Med Chem; 1995 Nov; 38(24):4760-3. PubMed ID: 7490724 [No Abstract] [Full Text] [Related]